Showing results (161-170 of 422) with videos related to

Sort By:
Pageof 43
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOCChristiane Wehrmann, Stefan Senftleben, Carolin Zachert, et al.
Science (New York, N.Y.)|April 23, 2016
All-optical control and metrology of electron pulsesC Kealhofer, W Schneider, D Ehberger, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CTHarshad R Kulkarni, Vikas Prasad, Daniel Kaemmerer, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumorMila Todorović-Tirnanić, Daniel Kaemmerer, Vikas Prasad, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1997
[Functional/metabolic CAD diagnosis: arbutamine-RNV, stress-Echo, Tl-SPECT and gated FDG-PET]S Adams, R P Baum, M Scholz, et al.
Clinical Nuclear Medicine|October 31, 2019
Metastatic Nasopharyngeal Carcinoma Treated With Intraarterial Combined With Intravenous Peptide Receptor Radionuclide TherapyWenjia Zhu, Jingjing Zhang, Aviral Singh, et al.
Seminars in Nuclear Medicine|April 13, 2016
Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin AnaloguesAli Salavati, Ameya Puranik, Harshad R Kulkarni, et al.
Clinical Nuclear Medicine|September 5, 2018
Pregnancy and Delivery After PRRT Without SequelaeJingjing Zhang, Harshad R Kulkarni, Coline Lehmann, et al.
Pageof 43